No Data
No Data
BAIYUNSHAN PH (600332.SH): Subsidiary recognized as a high-tech enterprise.
On February 19, Gelonghui reported that BAIYUNSHAN PH (600332.SH) announced that four of its subsidiaries, including Guangzhou BAIYUNSHAN PH Guanghua Pharmaceutical Co., Ltd. and Guangyao Wanglaoji (Bijie) Industrial Co., Ltd., have passed the high-tech enterprise certification and received the "High-tech Enterprise Certificate" jointly issued by the provincial department of science and technology, the finance department, and the tax bureau where these companies are registered.
Express News | Guangzhou Baiyunshan Pharmaceutical - Received Written Resignation From Wu Changhai as Executive Director
Baiyunshan Pharmaceutical Gets Regulatory Approval to Amend Drug Production License
The subsidiary of BAIYUNSHAN PH (00874.HK) has reduced the production line at He Jigong Pharmaceutical Factory.
On February 12, Gelonghui reported that BAIYUNSHAN PH (00874.HK) announced that recently, its subsidiary Guangzhou BAIYUNSHAN Pharmaceutical Group Co., Ltd. Huo Jigong Pharmaceutical Factory (hereinafter referred to as "Huo Jigong Pharmaceutical Factory") received the "Pharmaceutical Production License" approved and issued by the Guangdong Provincial Pharmaceutical Administration, allowing Huo Jigong Pharmaceutical Factory to reduce its production lines. The changes to the copy of the Pharmaceutical Production License are as follows: Huo Jigong Pharmaceutical Factory is authorized to reduce the production line in the workshop "Xingzhou Manufacturing Department" located at the production address "No. 4, South Chuangye Avenue, Mingzhu Industrial Park, Conghua City, Guangzhou (except Building K1)" for the production line "F Building." The production scope of the F Building production line.
BAIYUNSHAN PH (00874) has completed the change of its legal representative and obtained a new business license.
BAIYUNSHAN PH (00874) issued an announcement, Guangzhou BAIYUNSHAN PH Pharmaceutical Group Co., Ltd. ("the company") in 2025...
Earnings Working Against Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's (HKG:874) Share Price